| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.09 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |